Structure-based design and optimization of ligands for novel antiviral strategies
Neutralizing antibodies that bind to viral fusion proteins represent a promising strategy for protection from viral infections. Such antibodies can also serve as templates for the generation of peptides, which retain the ability to bind to viral proteins. In the present project, the known complexes between antibodies and the SARS CoV-2 spike are analyzed to design antibody-derived peptides that bind to the spike protein thereby blocking viral infection. For that purpose, a computational workflow is developed that uses molecular dynamics (MD) simulations to identify the most promising peptides for further experimental testing.